BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 0.9320
-0.0080 (-0.85%)
Apr 15, 2026, 4:59 PM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 465.4 million as of April 15, 2026. Its market cap has decreased by -23.72% in one year.
Market Cap
465.40M
Enterprise Value
418.03M
Revenue
40.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.93
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 465.40M, an increase of 518.24%. That is a compound annual growth rate of 9.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 465.40M | -7.84% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.07T |
| Genmab | 109.89B |
| Coloplast | 95.67B |
| ALK-Abelló | 47.15B |
| Gubra | 5.40B |
| ChemoMetec | 5.28B |
| Pharma Equity Group | 104.59M |
| ViroGates | 94.68M |